Abacavir sulfate is a potent HIV-specific agent widely utilized in the management of human immunodeficiency virus (HIV) infection. It exerts its therapeutic effect by competitively inhibiting the activity of the viral reverse transcriptase enzyme, thereby suppressing the conversion of HIV RNA to DNA. This inhibition disrupts the viral replication,